Board of Advisors

LSC    Philly    Join 

Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Annually, our Advisors make a personal financial contribution to cover LSC’s administrative costs, allowing us to channel money raised from our event fundraisers, Corporate Membership Program, and from individuals to our partner organizations.

Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort.

PHILADELPHIA BOARD OF ADVISORS

ABCDEFGHIJKLMNOPQRSTUVWXYZ
Tom Anderson

Tom Anderson

CEO

SwanBio Therapeutics

Armando Anido

Armando Anido

Chairman & CEO

Zynerba Pharmaceuticals

Scott Applebaum

Scott Applebaum

SVP & Chief Legal and Compliance Officer

Trevena

Usman

Usman "Oz" Azam

President & CEO

Tmunity

Lou Beardell

Lou Beardell

Partner

Morgan Lewis & Bockius

Kelly Beck

Kelly Beck

CEO

PolyCore Therapeutics

Carrie Bourdow

Carrie Bourdow

President & CEO

Trevena

Derek Bowen

Derek Bowen

Vice President

Blackfynn

Scott  Braunstein

Scott Braunstein

CEO

Marinus Therapeutics

Clifford Brechner

Clifford Brechner

Vice President

Colliers

Christopher Burns

Christopher Burns

President & CEO

Venatorx

Rachael Bushey

Rachael Bushey

Partner

Troutman Pepper

Ron Cariola

Ron Cariola

International Director

JLL

Barb Carlin

Barb Carlin

Managing Director - MidAtlantic

Danforth Advisors

Brett Ciarelli

Brett Ciarelli

Sr. Vice President

Morgan Stanley Private Wealth Management

John Crowley

John Crowley

Chairman and CEO

Amicus Therapeutics

Lisa Dalton

Lisa Dalton

Chief People Officer

Spark Therapeutics

Jeff Dayno

Jeff Dayno

Chief Medical Officer

Harmony Biosciences

Phillip Duffy

Phillip Duffy

Korn Ferry

John Fry

John Fry

President

Drexel University

Steven Gelone

Steven Gelone

President & COO

Nabriva Therapeutics

John Gerard

John Gerard

Retired Partner

KPMG

Maxine Gowen

Maxine Gowen

CEO

Tamuro Bio

Daniel Hayes

Daniel Hayes

Principal, Life Sciences

CliftonLarsonAllen LLP

Thomas Hess

Thomas Hess

CFO

Genomind

Stephen Hurly

Stephen Hurly

CEO

LAVA Therapeutics

John Jacobs

John Jacobs

Chairman and CEO

Harmony Biosciences

Steve Jannetta

Steve Jannetta

Partner

Morgan Lewis & Bockius

Steven Kelly

Steven Kelly

President & CEO

Carisma Therapeutics

Martin Lehr

Martin Lehr

CEO

Context Therapeutics

Jeff Libson

Jeff Libson

Partner

Cooley

Evan Loh

Evan Loh

CEO

Paratek Pharmaceuticals

Kevin Mahoney

Kevin Mahoney

CEO

University of Pennsylvania Health System

Francesco Maria Lavino

Francesco Maria Lavino

CCO

Nabriva Therapeutics

Jean Marie Markham

Jean Marie Markham

Founder & CEO

Clinlogix

John Maslowski

John Maslowski

CEO

Castle Creek Biosciences, Inc.

Steven Nichtberger

Steven Nichtberger

CEO, President & Chairman

Cabaletta Bio

Shawn Patrick O'Brien
Bruce Peacock

Bruce Peacock

Biopharmaceutical executive and board member

Matthew Pearson

Matthew Pearson

Partner

Akin Gump

Mike Pellini

Mike Pellini

Managing Partner

Section 32

Jill Quigley

Jill Quigley

Chief Operating Officer

Passage Bio

Robert Radie

Robert Radie

CEO & Chairman

Neuraptive Therapeutics

Maryellen Royle

Maryellen Royle

Partner

EvokeKYNE

Rob Sarisky

Rob Sarisky

Biopharmaceutical executive and board member

Kathleen Shay

Kathleen Shay

Partner

Duane Morris

Bruce Shook

Bruce Shook

Biopharmaceutical executive and board member

Steve Simpson

Steve Simpson

Partner

EY

Judith Steenbergen

Judith Steenbergen

President

SMAC LLC

Dan Strauss

Dan Strauss

Partner

Klein Hersh International

Joseph Truitt

Joseph Truitt

Biopharmaceutical executive and board member

Evan Tzanis

Evan Tzanis

Executive Vice President

Neuraptive Therapeutics

Tyler Vandegrift

Tyler Vandegrift

Managing Director

JLL

Stephen Webster

Stephen Webster

Biopharmaceutical executive and board member

Chris Yochim

Chris Yochim

Head of BD

NIIMBL